COLD AGGLUTININ DISEASE

Clinical trials for COLD AGGLUTININ DISEASE explained in plain language.

Never miss a new study

Get alerted when new COLD AGGLUTININ DISEASE trials appear

Sign up with your email to follow new studies for COLD AGGLUTININ DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 4 Not yet finished but already full! 1 Completed 3 Terminated 1

Experimental drug for rare blood disorder tested for long-term safety

Disease control Terminated

This study tested the long-term safety of a drug called SAR445088 in people with cold agglutinin disease, a rare condition where the immune system attacks red blood cells. Only 9 participants were enrolled, and the study was terminated early. The goal was to see if the drug is sa…

Matched conditions: COLD AGGLUTININ DISEASE

Phase: PHASE1 • Sponsor: Bioverativ, a Sanofi company • Aim: Disease control

Last updated Jun 26, 2026 16:38 UTC

COLD AGGLUTININ DISEASE

Get alerted when new COLD AGGLUTININ DISEASE trials appear

Experimental drug for rare blood disorder tested for long-term safety